2015 News Articles

All | 2019 | 2018 | 2017 | 2016

Speaking Out: Some Cancer Screenings Can Lead to Unnecessary Treatment

Researchers have found evidence that not all cancers detected by screening tests need to be treated. Some would never affect your health. In fact, treating them may cause more harm than good. While we once believed that... Read More

POSTED: 12/17/2015

Low Income Is a Barrier to Clinical Trial Enrollment, Study Suggests

In a recent survey study, researchers affiliated with the NCI Community Oncology Research Program (NCORP) found that patients with annual household incomes below $50,000 were less likely to participate in a cancer clinical... Read More

POSTED: 11/16/2015

Shared Decision Making to Improve Cancer Screening Choices

When people in this country reach middle age, they usually have to grapple with an array of cancer screening options. Often those choices are presented in the form of frequently conflicting guidelines from the U.S.... Read More

POSTED: 11/03/2015

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Etiologic and Early Marker Studies (EEMS) has a new application process for specimen requests. Researchers planning to submit a grant application in... Read More

POSTED: 11/02/2015

NCI's Outstanding Investigator Award supports accomplished leaders in cancer research, who are providing significant contributions toward understanding cancer and developing applications that may lead to a breakthrough in... Read More

POSTED: 10/26/2015

The NCI has awarded eight grants to create the Consortium for Molecular Characterization of Screen-Detected Lesions. The consortium has seven molecular characterization laboratories (MCLs) and a coordinating center, and is... Read More

POSTED: 10/14/2015

By the numbers, the first year of NCI’s Community Oncology Research Program (NCORP) has made progress in clinical trials for prevention, control, health-related quality of life, comparative effectiveness and screening;... Read More

POSTED: 09/29/2015

The NCI Division of Cancer Prevention awarded eight grants to create the Consortium for Imaging and Biomarkers (CIB) on August 3, 2015. The consortium focuses on combining imaging methods, such as computed tomography (CT... Read More

POSTED: 09/11/2015

Overdiagnosis of Cancer: Bringing an Important Problem into Focus

For the third consecutive year, experts from around the world will convene to discuss the dilemma of overdiagnosis in many types of disease. Overdiagnosis is generally defined as the diagnosis of a disease or condition that... Read More

POSTED: 08/28/2015

Microscopist analyzing biopsy samples

Risk of Breast Cancer Death Is Low after a Diagnosis of Ductal Carcinoma in Situ

A new study suggests that women who are diagnosed with abnormal cells in the lining of a breast duct—a noninvasive condition called ductal carcinoma in situ, or DCIS—generally have a low risk of dying from breast cancer. Read More

POSTED: 08/26/2015

NCI's Division of Cancer Prevention is a leading participant for a key initiative in the National Institutes of Health (NIH) Glycoscience Common Fund program. This program supports development of accessible and affordable... Read More

POSTED: 07/30/2015

U.S. Indoor Tanning Rates Are Dropping, But Still High

The number of people who tan indoors appears to be dropping, according to a new study from researchers at NCI and the U.S. Centers for Disease Control and Prevention (CDC). Read More

POSTED: 07/24/2015

Benefit of Fewer than Three Doses of HPV Vaccine Reported

Results of a combined analysis of data from two independent trials of the human papillomavirus (HPV) vaccine strengthen previous findings from one of the trials that young women who received three, two, or one dose of the... Read More

POSTED: 06/10/2015

NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities

Investigators for the nationwide trial, NCI-MATCH: Molecular Analysis for Therapy Choice (EAY131), announced today at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago that the precision... Read More

POSTED: 06/01/2015

For nearly 30 years, the NCI Cancer Prevention Fellowship Program (CPFP) has provided funding support for post-doctoral Fellows with a goal to train the future generation of researchers and leaders in the field. "Our... Read More

POSTED: 05/18/2015

An interactive map of the NCI Community Oncology Research Program (NCORP) with detailed information on hundreds of community sites that take part in clinical trials is available on the NCORP website. NCORP Map NCORP... Read More

POSTED: 05/12/2015

Dr. Barry Kramer: The Importance of Cancer Prevention Research and Its Challenges

A question that inevitably gets raised almost any time cancer is discussed is how we can make greater strides in prevention and early detection. It’s a question much discussed at NCI, and a goal we are pursuing with a... Read More

POSTED: 04/01/2015

The NCI Division of Cancer Prevention’s Phase 0/I/II Cancer Prevention Clinical Trials Program, also known as the Consortia for Early Phase Prevention Trials, is beginning a new round of studies in the effort toward... Read More

POSTED: 03/23/2015

Treatment Helps Preserve Fertility in Some Women with Breast Cancer

Results from an NCI-sponsored clinical trial show that giving some younger women with early-stage breast cancer a hormone-suppressing drug in addition to chemotherapy helps to preserve ovarian function and improves their... Read More

POSTED: 03/13/2015

Naproxen Plus Acid Blocking Drug Shows Promise in Preventing Bladder Cancer

The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-... Read More

POSTED: 03/11/2015

Harold Varmus to Step Down as Director of the National Cancer Institute

To NCI staff, grantees, and advisors: I am writing to let you know that I sent a letter today to President Obama, informing him that I plan to leave the Directorship of the National Cancer Institute at the end of this month... Read More

POSTED: 03/04/2015

ECOG-ACRIN Opens Trial E4112 Using Breast MRI and Genomics for Treatment Decision-Making in DCIS

ECOG-ACRIN Opens Trial E4112 Using Breast MRI and Genomics for Treatment Decision-Making in DCIS A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group addresses questions about the over-treatment of ductal... Read More

POSTED: 03/02/2015

Early detection research funded by the NCI's Division of Cancer Prevention has positively steered both public health and clinical outcomes, and set the stage for findings in the next generation of research. Large Trials "... Read More

POSTED: 01/26/2015

The NCI Central Institutional Review Board (CIRB) Initiative announced the establishment of the Cancer Prevention and Control (CPC) CIRB January 14, extending the benefits of centralized review to investigators... Read More

POSTED: 01/15/2015